The impact of first year adherence to antiretroviral therapy on long-term clinical and immunological outcomes in the DART trial in Uganda and Zimbabwe.

The impact of first year adherence to antiretroviral therapy on long-term clinical and immunological outcomes in the DART trial in Uganda and Zimbabwe.

OBJECTIVES: To describe associations between different summaries of adherence in the first year on antiretroviral therapy (ART) and the subsequent risk of mortality, to identify patients at high risk because of early adherence behaviour. METHODS: We previously described an approach where adherence b...

Descripció completa

Dades bibliogràfiques
Autors principals:	Kiwuwa-Muyingo, S, Walker, A, Oja, H, Levin, J, Miiro, G, Katabira, E, Kityo, C, Hakim, J, Todd, J
Format:	Journal article
Idioma:	English
Publicat:	2012

Ítems similars

Patterns of individual and population-level adherence to antiretroviral therapy and risk factors for poor adherence in the first year of the DART trial in Uganda and Zimbabwe.
per: Muyingo, S, et al.
Publicat: (2008)

Clustering based on adherence data.
per: Kiwuwa-Muyingo, S, et al.
Publicat: (2011)

Clinical differences between younger and older adults with HIV/AIDS starting antiretroviral therapy in Uganda and Zimbabwe: a secondary analysis of the DART trial
per: Parikh, S, et al.
Publicat: (2013)

Mortality in the year following antiretroviral therapy initiation in HIV-infected adults and children in Uganda and Zimbabwe.
per: Walker, A, et al.
Publicat: (2012)

Clinical differences between younger and older adults with HIV/AIDS starting antiretroviral therapy in Uganda and Zimbabwe: a secondary analysis of the DART trial.
per: Sujal M Parikh, et al.
Publicat: (2013-01-01)

Impact of second-line antiretroviral regimens on lipid profiles in an African setting: the DART trial sub-study.
per: Gomo, Z, et al.
Publicat: (2014)

Cost Effectiveness Analysis of Clinically Driven versus Routine Laboratory Monitoring of Antiretroviral Therapy in Uganda and Zimbabwe
per: Lara, A, et al.
Publicat: (2012)

Dynamic logistic regression model and population attributable fraction to investigate the association between adherence, missed visits and mortality: a study of HIV-infected adults surviving the first year of ART.
per: Kiwuwa-Muyingo, S, et al.
Publicat: (2013)

Cost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and Zimbabwe.
per: Antonieta Medina Lara, et al.
Publicat: (2012-01-01)

Long-term antiretroviral treatment adherence in HIV-infected adolescents and adults in Uganda: a qualitative study
per: Inzaule, S, et al.
Publicat: (2016)

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial.
per: Mugyenyi, P, et al.
Publicat: (2010)

Long-Term Antiretroviral Treatment Adherence in HIV-Infected Adolescents and Adults in Uganda: A Qualitative Study.
per: Seth C Inzaule, et al.
Publicat: (2016-01-01)

Clinic Attendance for Medication Refills and Medication Adherence amongst an Antiretroviral Treatment Cohort in Uganda: A Prospective Study
per: Setor Kunutsor, et al.
Publicat: (2010-01-01)

Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort.
per: Walker, A, et al.
Publicat: (2010)

Virologic versus immunologic monitoring and the rate of accumulated genotypic resistance to first-line antiretroviral drugs in Uganda
per: Reynolds Steven J, et al.
Publicat: (2012-12-01)

Correction: Long-Term Antiretroviral Treatment Adherence in HIV-Infected Adolescents and Adults in Uganda: A Qualitative Study.
per: Seth C Inzaule, et al.
Publicat: (2017-01-01)

Depression at Treatment Initiation Predicts HIV Antiretroviral Adherence in Uganda
per: Glenn J. Wagner PhD, et al.
Publicat: (2017-01-01)

Prevalence, incidence and predictors of severe anaemia with zidovudine-containing regimens in African adults with HIV infection within the DART trial.
per: Ssali, F, et al.
Publicat: (2006)

The effect of AIDS defining conditions on immunological recovery among patients initiating antiretroviral therapy at Joint Clinical Research Centre, Uganda
per: Odere Mathew, et al.
Publicat: (2009-07-01)

HIV-associated anemia after 96 weeks on therapy: determinants across age ranges in Uganda and Zimbabwe.
per: Jaganath, D, et al.
Publicat: (2014)

The impact of attending a behavioural intervention on HIV incidence in Masaka, Uganda.
per: Quigley, M, et al.
Publicat: (2004)

Effect of justification of wife-beating on experiences of intimate partner violence among men and women in Uganda: A propensity-score matched analysis of the 2016 Demographic Health Survey data.
per: Damazo T Kadengye, et al.
Publicat: (2023-01-01)

Group counselling for adherence support among young people failing first-line antiretroviral therapy in Zimbabwe
per: Bahati Kasimonje, et al.
Publicat: (2021-10-01)

Food insecurity as a barrier to sustained antiretroviral therapy adherence in Uganda.
per: Sheri D Weiser, et al.
Publicat: (2010-04-01)

Validity and Reliability of a Self-Reported Measure of Antihypertensive Medication Adherence in Uganda.
per: Samson Okello, et al.
Publicat: (2016-01-01)

Poor immunological recovery among severely immunosuppressed antiretroviral therapy-naïve Ugandans
per: Nanzigu S, et al.
Publicat: (2013-12-01)

Perspectives of health workers on the facilitators and barriers to antiretroviral therapy adherence following intensive adherence counseling in Northern Uganda
per: Humphrey Beja, et al.
Publicat: (2025-01-01)

Aerobic-exercise training effects on immunological markers in individuals on highly active antiretroviral therapy in Uganda
per: Constance Adron Nakayiza Nsibambi, et al.
Publicat: (2024-06-01)

Adherence to antiretroviral therapy in Jinja, Uganda: a six-year follow-up study.
per: Martin Mbonye, et al.
Publicat: (2013-01-01)

Improving adherence to antiretroviral treatment in Uganda with a low-resource facility-based intervention
per: Celestino Obua, et al.
Publicat: (2014-06-01)

Durable Suppression of HIV-1 after Virologic Monitoring-Based Antiretroviral Adherence Counseling in Rakai, Uganda.
per: Alexander Billioux, et al.
Publicat: (2015-01-01)

The Role of Mass Media Campaigns in Improving Adherence to Antiretroviral Therapy Among Adolescents Living with HIV in Southwestern Uganda
per: Akankunda S, et al.
Publicat: (2022-08-01)

Prevalence, correlates for early neurological disorders and association with functioning among children and adolescents with HIV/AIDS in Uganda
per: Richard Stephen Mpango, et al.
Publicat: (2019-01-01)

Experiencing antiretroviral adherence: helping healthcare staff better understand adherence to paediatric antiretrovirals
per: Benjamin R Phelps, et al.
Publicat: (2010-01-01)

High level of viral suppression and low switch rate to second-line antiretroviral therapy among HIV-infected adult patients followed over five years: retrospective analysis of the DART trial
per: Kityo, C, et al.
Publicat: (2014)

Factors associated with HIV testing among youth in Tanzania based on the 2016-2017 Tanzania HIV Impact Survey (THIS).
per: Yan Wang, et al.
Publicat: (2022-01-01)

Factors associated with HIV testing among youth in Tanzania based on the 2016–2017 Tanzania HIV Impact Survey (THIS)
per: Yan Wang, et al.
Publicat: (2022-01-01)

Excellent adherence to antiretrovirals in HIV+ Zambian children is compromised by disrupted routine, HIV nondisclosure, and paradoxical income effects
per: Haberer, J, et al.
Publicat: (2011)

Adherence to contemporary antiretroviral treatment regimens and impact on immunological and virologic outcomes in a US healthcare system.
per: Christophe T Tchakoute, et al.
Publicat: (2022-01-01)

Implementation of Electronic Adherence Monitors and Associated Interventions for Routine HIV Antiretroviral Therapy in Uganda: Promising Findings
per: Jessica E. Haberer, et al.
Publicat: (2022-07-01)